Cargando…
Pharmacologic treatment of depression in patients with myocardial infarction
Depression is a common medical problem and is more prevalent among patients with coronary artery disease. Whether early detection and treatment of depression will enhance cardiovascular outcome is uncertain. Obviously, the safety and efficacy of the anti-depression drugs is an important link. This a...
Autores principales: | Ha, Jeong-Hoon, Wong, Cheuk-Kit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390082/ https://www.ncbi.nlm.nih.gov/pubmed/22783296 http://dx.doi.org/10.3724/SP.J.1263.2011.00121 |
Ejemplares similares
-
Clinical Benefit of Statins in Korean Patients with Acute Myocardial Infarction: Experience of the Korea Acute Myocardial Infarction Registry
por: Cho, Kyung Hoon, et al.
Publicado: (2020) -
Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2020) -
Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients
por: Grigoriou, Stefania S., et al.
Publicado: (2015) -
Pharmacological Treatments for Patients with Treatment-Resistant Depression
por: Ruberto, Valerie L., et al.
Publicado: (2020) -
Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderly
por: Usta, Coşkun, et al.
Publicado: (2017)